Rat Anti-Kinase Suppressor Of Ras Monoclonal Antibody, Unconjugated, Clone MINT/1/4 from GeneTex
Mouse Anti-NY-ESO-1 Monoclonal Antibody, Unconjugated, Clone E978 from Upstate
HRP-STABILPLUS from AbD Serotec
Xylanase Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
Biology Products:(Date:11/24/2009)...ire-FirstCall/ -- Sigma-Aldrich Corporation (Nasda...nference on Tuesday, December 1st at 1:45 PM GMT i...isten via live audio broadcast over the Internet a...rich.com/ . Users can click the "Webcast" icon t... Sigma-Aldrich is a leading Life Science and Hig...
(Date:11/24/2009)... NeurogesX, Inc. (Nasdaq...developing and commercializing novel pain manageme..., President and Chief Executive Officer, is schedu...alth Care Conference, to be held December 1-2, 200...rk. ,, Mr. DiTonno and Stephen Ghiglieri, Chie...
(Date:11/24/2009)...t has been met for patients with advanced-stage, ...ITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna Zent..."), a global biopharmaceutical company focused on ...sitive efficacy data from a Phase 2 study with its...ormerly AN-152), in patients with advanced or recu...
(Date:11/24/2009)...4 Genomic Health, Inc. (...Genomic Health,s Executive Chairman, will present ...rence in New York City on Tuesday, December 1, 200...subsequently archived webcast of the presentation,...ealth,s website at http://investor.genomichealth....
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2